HORIZON HEALTH INTERNATIONAL CORP. (PINK SHEETS: HZHI) (the Company) is pleased to announce additional FDA Label application of Enteric Lactoferrin.

Mr. Rocco Di Fruscia, President of Horizon Health International Corp., an emerging specialty pharmaceutical company is pleased to announce that NRL Pharma Canada Inc. a wholly owned subsidiary of HORIZON, has requested FDA Label approval for the claims in the US Patent Application Number 20090082269 to commercialize this application for the treatment of Anti-Aging Effects using its Enteric Lactoferrin.

The President, Mr. Fruscia says: "We believe with the aging Baby Boomers Generation, we have enormous potential in this market with our Enteric Lactoferrin based on most recent results".

Anti-aging Effects of Lactoferrin

Reactive Oxygen Species Promotes Aging

Aging is the accumulation of changes in organisms, such as the appearance of wrinkles and mottled skin. Oxygen and radical oxygen species are the key risk factors for aging. Molecular dioxygen (O2) is essential for cellular respiration in all aerobic organisms. In the mitochondria, oxygen is used to generate adenosine triphosphate (ATP) during oxidative phosphorylation. In the absence of oxygen supply, the individual suffers brain death within 5 minutes, and the heart stops beating within 10 to 20 minutes. Although oxygen is essential for energy production, its by-product is harmful to cells. During the process of mitochondrial energy production, a very low but significant amount of the hydroxyl radical (OH.) is produced. The hydroxyl radical is highly reactive, and it attacks any compound immediately after it is produced.

Visible Anti-aging Effects of Lactoferrin

"Stay Young" is eternal issue for cosmetic industry. There are huge numbers of cosmetics stipulating for eternal youth. However, there is only one that all-trans retinoic acid can topically rejuvenate aged skin. The orally effective product that can rejuvenate aged skin has huge potentiality as dietary supplement.

- Lactoferrin can rejuvenate aged skin and this effect relates to its property preventing oxidative stress.

- improves cracking skin of heel - improving flecks on skin - Increases collagen synthesis on skin

- Improves keloid on skin

Company's business:

HORIZON's Subsidiary 'NRL Pharma Canada Inc.' is an emerging specialty pharmaceutical company that is committed to Research & Development of Lactoferrin and to supply its Patented delivery systems of enteric lactoferrin, and "PEG-lactoferrin."

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports.

Contacts: Horizon Health International Corp. Rocco Di Fruscia President & CEO 514 586 3799 horizonhealth@shaw.ca www.horizonhealthinternational.com

Horizon Health (CE) (USOTC:HZHI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Horizon Health (CE) Charts.
Horizon Health (CE) (USOTC:HZHI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Horizon Health (CE) Charts.